Preliminary individualized chemotherapy for malignant astrocytomas based on O6-methylguanine-deoxyribonucleic acid methyltransferase methylation analysis

Neurologia Medico-Chirurgica

Volumn 46, Issue 8, 2006, Pages 387-393

  Watanabe, Takao ^a   Katayama, Yoichi ^a   Ogino, Akiyoshi ^a   Ohta, Takashi ^a   Yoshino, Atsuo ^a   Fukushima, Takao ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Anaplastic astrocytoma; Chemotherapy; Glioblastoma multiforme; O 6 methylguanine deoxyribonucleic acid methyltransferase methylation

Indexed keywords

CARBOPLATIN; ETOPOSIDE; INTERFERON; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE FREE INTERVAL; DRUG EFFICACY; DRUG RESPONSE; DRUG TOLERANCE; FEMALE; HUMAN; MALE; METHYLATION; MINIMAL RESIDUAL DISEASE; TREATMENT RESPONSE;

ADULT; AGED; ALKYLATING AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ASTROCYTOMA; BRAIN NEOPLASMS; CHEMOTHERAPY, ADJUVANT; DNA METHYLATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NITROSOUREA COMPOUNDS; O(6)-METHYLGUANINE-DNA METHYLTRANSFERASE;

EID: 33748043318     PISSN: 04708105     EISSN: 13498029     Source Type: Journal    
DOI: 10.2176/nmc.46.387     Document Type: Article

References (27)

1. Ameri A, Poisson M, Chauveinc L, Chen QM, Delattre JY: Treatment of recurrent malignant supratentorial gliomas with the association of carboplatin and etoposide: a phase II study. J Neurooncol 32: 155-160, 1997
2. 6-Methylguanine-DNA methyltransferase methylation in serum and tumor DNA predicts response to 1, 3-bis(2-chloroethyl)-1-nitrosourea but not to temozolamide plus cisplatin in glioblastoma multiforme. Clin Cancer Res 9: 1461-1468, 2003
3. 6- alkylguanine-DNA methyltransferase. Br J Cancer 75: 500-505, 1997
4. D'Atri S, Graziani G, Lacal PM, Nistico V, Gilberti S, Faraoni I, Watson AJ, Bonmassar E, Margison GP: Attenuation of O(6)-methylguanine-DNA methyltransferase activity and mRNA levels by cisplatin and temozolomide in jurkat cells. J Pharmacol Exp Ther 294: 664-671, 2000
5. Esteller M, Garcia-Foncillas J, Andion E, Goodman S, Hidalgo OF, Vanaclocha V, Baylin SB, Herman JG: Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents. N Engl J Med 343: 1350-1354, 2000
6. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797, 1999
7. Gerson SL: Clinical relevance of MGMT in the treatment of cancer. J Clin Oncol 20: 2388-2399, 2002
8. Grossman SA, O'Neil A, Grunnet M, Mehta M, Pearlman JL, Wagner H, Gilbert M, Newton HB, Hellman R: Phase III study comparing three cycles of infusional carmustine and cisplatin followed by radiation therapy with radiation therapy and concurrent carmustine in patients with newly diagnosed supratentorial glioblastoma multiforme: Eastern Cooperative Oncology Group Trial 2394. J Clin Oncol 21: 1485-1491, 2003
9. Herman JG, Graff JR, Myöhänen S, Nelkin BD, Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci U S A 93: 9821-9826, 1996
10. Jeremic B, Grujicic D, Jevremovic S, Stanisavljevic B, Milojevic L, Djuric L, Mijatovic L: Carboplatin and etoposide chemotherapy regimen for recurrent malignant glioma: a phase II study. J Clin Oncol 7: 1074-1077, 1992
11. Jeremic B, Shibamoto Y, Grujicic D, Stojanovic M, Milicic B, Nikolic N, Dagovic A, Aleksandrovic J: Concurrent accelerated hyperfractionated radiation therapy and carboplatin/etoposide in patients with malignant glioma: long-term results of a phase II study. J Neurooncol 51: 133-141, 2001
12. Kleihues P, Cavenee WK (eds): Pathology and Genetics of Tumours of the Nervous System. Lyon, International Agency for Research on Cancer, 2000, pp 27-39
13. 6-methylguanine-DNA methyltransferase is an independent predictor of shortened progression free survival in patients with low-grade diffuse astrocytomas. Brain Pathol 13: 176-184, 2003
14. Medical Research Council Brian Tumor Working Party: Randomized trial of procarbazine, lomustine, and vincristine in the adjuvant treatment of high-grade astrocytoma: a Medical Research Council trial. J Clin Oncol 19: 509-518, 2001
15. Natsume A, Ishii D, Wakabayashi T, Tsuno T, Hatano H, Mizuno M, Yoshida J: IFN-beta down-regulates the expression of DNA repair gene MGMT and sensitizes resistant glioma cells to temozolomide. Cancer Res 65: 7573-7579, 2005
16. Peterson K, Harsh G IV, Fisher PG, Adler J, Le Q: Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma. J Neurooncol 53: 27-32, 2001
17. 6- methylguanine-DNA methyltransferase (MGMT) on the cytotoxic and recombinogenic activity of different antineoplastic drugs. Int J Cancer 65: 506-512, 1996
18. 6-benzylguanine for patients with nitrosourea-resistant recurrent or progressive malignant glioma. J Clin Oncol 20: 2277-2283, 2002
19. Silvani A, Eoli M, Salmaggi A, Lamperti E, Maccagnano E, Broggi G, Boiardi A: Phase II trial of cisplatin plus temozolomide, in recurrent and progressive malignant glioma patients. J Neurooncol 66: 203-208, 2004
20. Stewart LA: Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomized trials. Lancet 359: 1011-1018, 2002
21. Tanaka S, Kamitani H, Amin MR, Watanabe T, Oka H, Fujii K, Nagashima T, Hori T: Preliminary individual adjuvant therapy for gliomas based on the results of molecular biological analyses for drug-resistance genes. J Neurooncol 46: 157-171, 2000
22. 6-methylguanine-DNA methyltransferase by dexamethasone in glioblastomas. J Neurosurg 101: 659-663, 2004
23. Watanabe K, Kanaya H, Fujisawa Y, Kim P: Combination chemotherapy using carboplatin (JM-8) and etoposide (JET therapy) for recurrent malignant glioma: a phase II study. Acta Neurochir (Wien) 144: 1265-1270, 2002
24. 6-Methylguanine-DNA methyltransferase methylation and TP53 mutation in malignant astrocytomas and their relationships with clinical course. Int J Cancer 113: 581-587, 2005
25. Watanabe T, Katayama Y, Yoshino A, Fukaya C, Yamamoto T: Human interferon beta, nimustine hydrochloride, and radiation therapy in the treatment of newly diagnosed malignant astrocytomas. J Neurooncol 72: 57-62, 2005
26. ARF tumor suppressor pathway in low-grade diffuse astrocytomas and its influence on clinical course. Clin Cancer Res 9: 4884-4890, 2003
27. INK4a genes in oligodendrogliomas. Acta Neuropathol (Berl) 101: 185-189, 2001